Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options

South African Family Practice

 
 
Field Value
 
Title Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
 
Creator Schellack, Gustav Meyer, J. C. Schellack, Natalie
 
Subject — GORD; gastro-oesophageal reflux; PPIs; proton-pump inhibitors; cost-effectiveness
Description Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.
 
Publisher AOSIS
 
Contributor
Date 2016-03-01
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article —
Format application/pdf
Identifier 10.4102/safp.v58i2.4468
 
Source South African Family Practice; Vol 58, No 2 (2016): March/April; 6 2078-6204 2078-6190
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://safpj.co.za/index.php/safpj/article/view/4468/5292
 
Coverage — — —
ADVERTISEMENT